1Donnez J, Dolmans MM. Fertility preservation in women[J].Nat Rev Endocrinol, 2013, 9(12):735 -749.
2Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010[J]. CA Cancer J Clin, 2010, 60(5):277-300.
3Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte[J]. Hum Reprod, 2003, 18(1):117-121.
4Donnez J, Dolmans MM, Demylle D, et al. Restoration of ovarian function after orthotopic (intraovarian and periovarian) transplantation of cryopreserved ovarian tissue in a woman treated by bone marrow transplantation for sickle cell anaemia: case report[J]. Hum Reprod, 2006, 21(1): 183-188.
5Del Mastro L, Boni L, Michelotti A, et al. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial [J]. JAMA, 2011,306(3):269-276.
6Gerber B, yon Minckwitz G, Stehle H, et al. Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study[J]. J Clin Oncol, 2011, 29(17): 2334-2341.
7Munster PN, Moore AP, Ismail-Khan R, et al. Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer[J]. J Clin Oncol, 2012, 30(5): 533-538.
8Irtan S, Orbach D, Helfre S, et al. Ovarian transposition in prepubescent and adolescent girls with cancer[J]. Lancet Oncol, 2013, 14(13):e601-608.
9Harel S, Ferrne C, Poirot C. Management of fertility in patients treated for Hodgkin's lymphoma[J]. Haematologica, 2011, 96(11):1692-1699.
10yon Wolff M, Dian D. Fertility preservation in women with malignant tumors and gonadotoxic treatments[J]. Dtsch Arztebl Int, 2012, 109(12):220-226.
